Global Health Limited has informed the Exchange that Record date for the purpose of Dividend is 22-Aug-2025.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) announced strong Q1 FY26 results with consolidated revenue rising ~20% to Rs. 1,030.8 crore and profit after tax jumping ~50% to Rs. 159 crore, driven by higher patient volumes and operational efficiencies. On a standalone basis, revenue grew ~16% to Rs. 882.2 crore while PAT rose ~40% to Rs. 152 crore. The board fixed August 22, 2025 as the record date for a final dividend of Rs. 0.50 per equity share for FY25, subject to shareholder approval at the September 19, 2025 AGM. The board also recommended re-appointment of Dr. Naresh Trehan as Chairman & MD for another 5 years from August 2026, and re-appointed two independent directors. MAKS & Co was appointed as new Secretarial Auditor for 5 years from FY26. Comparative figures were restated due to the amalgamation of Medanta Holdings Private Limited with the company.
Strong Q1 earnings with double-digit revenue growth and ~50% PAT growth signal robust operational performance, likely to support positive investor sentiment. The Rs. 0.50 final dividend rewards shareholders, while continuity in leadership with Dr. Trehan's re-appointment provides stability. The restated financials from the amalgamation may temporarily distort year-on-year comparisons.